Show Parent

January

ERJ Podcast Eur Respir J 2012; 39: E13
Prof. Brian James Whipp, 1937–2012: a master in respiratory and exercise physiology Palange P., Casaburi R., Ward S.A. Eur Respir J 2012; 39: 1-2
Pulmonary hypertension in patients with sickle cell disease: not so frequent but so different Simonneau G., Parent F. Eur Respir J 2012; 39: 3-4
The fibrocyte in pulmonary hypertension: we seek him here, we seek him there Toshner M.R., Morrell N.W. Eur Respir J 2012; 39: 5-6
Improving outcomes from community-acquired pneumonia: we need to be more sophisticated about cause and effect Waterer G.W., Lopez D. Eur Respir J 2012; 39: 7-8
Surrogate markers predicting overall survival for lung cancer: ELCWP recommendations Berghmans T., Pasleau F., Paesmans M., Bonduelle Y., Cadranel J., Cs Toth I., Garcia C., Giner V., Holbrechts S., Lafitte J.J., Lecomte J., Louviaux I., Markiewicz E., Meert A.P., Richez M., Roelandts M., Scherpereel A., Tulippe Ch., Van Houtte P., Van Schil P., Wachters C., Westeel V., Sculier J.P. Eur Respir J 2012; 39: 9-28
Airflow limitation, lung volumes and systemic inflammation in a general population Gläser S., Ittermann T., Koch B., Völzke H., Wallaschofski H., Nauck M., Warnke C., Vogelmeier C., Schulz H., Felix S.B., Ewert R., Schäper C. Eur Respir J 2012; 39: 29-37
Seasonality and determinants of moderate and severe COPD exacerbations in the TORCH study Jenkins C.R., Celli B., Anderson J.A., Ferguson G.T., Jones P.W., Vestbo J., Yates J.C., Calverley P.M.A. Eur Respir J 2012; 39: 38-45
The impact of weekends on outcome for acute exacerbations of COPD Barba R., Zapatero A., Losa J.E., Marco J., Plaza S., Rosado C., Canora J. Eur Respir J 2012; 39: 46-50
Unrecognised ventricular dysfunction in COPD Macchia A., Rodriguez Moncalvo J.J., Kleinert M., Comignani P.D., Gimeno G., Arakaki D., Laffaye N., Fuselli J.J., Massolin H.P., Gambarte J., Romero M., Tognoni G. Eur Respir J 2012; 39: 51-58
TOF-SIMS analysis of exhaled particles from patients with asthma and healthy controls Almstrand A-C., Josefson M., Bredberg A., Lausmaa J., Sjövall P., Larsson P., Olin A-C. Eur Respir J 2012; 39: 59-66
Farming in childhood, diet in adulthood and asthma history Varraso R., Oryszczyn M.P., Mathieu N., Le Moual N., Boutron-Ruault M.C., Clavel-Chapelon F., Romieu I., Kauffmann F. Eur Respir J 2012; 39: 67-75
Preschool asthma after bronchiolitis in infancy Koponen P., Helminen M., Paassilta M., Luukkaala T., Korppi M. Eur Respir J 2012; 39: 76-80
Duration and exclusiveness of breastfeeding and childhood asthma-related symptoms Sonnenschein-van der Voort A.M.M., Jaddoe V.W.V., van der Valk R.J.P., Willemsen S.P., Hofman A., Moll H.A., de Jongste J.C., Duijts L. Eur Respir J 2012; 39: 81-89
Parent misperception of control in childhood/adolescent asthma: the Room to Breathe survey Carroll W.D., Wildhaber J., Brand P.L.P. Eur Respir J 2012; 39: 90-96
Bioavailability of inhaled fluticasone propionate via chambers/masks in young children Blake K., Mehta R., Spencer T., Kunka R.L., Hendeles L. Eur Respir J 2012; 39: 97-103
Circulating fibrocytes are increased in children and young adults with pulmonary hypertension Yeager M.E., Nguyen C.M., Belchenko D.D., Colvin K.L., Takatsuki S., Ivy D.D., Stenmark K.R. Eur Respir J 2012; 39: 104-111
Pulmonary hypertension diagnosed by right heart catheterisation in sickle cell disease Fonseca G.H.H., Souza R., Salemi V.M.C., Jardim C.V.P., Gualandro S.F.M. Eur Respir J 2012; 39: 112-118
Diagnosis of CTEPH versus IPAH using capillary to end-tidal carbon dioxide gradients Scheidl S.J., Englisch C., Kovacs G., Reichenberger F., Schulz R., Breithecker A., Ghofrani H-A., Seeger W., Olschewski H. Eur Respir J 2012; 39: 119-124
Pulmonary fibrosis is associated with an elevated risk of thromboembolic disease Sprunger D.B., Olson A.L., Huie T.J., Fernandez-Perez E.R., Fischer A., Solomon J.J., Brown K.K., Swigris J.J. Eur Respir J 2012; 39: 125-132
Parenchymal trafficking of pleural mesothelial cells in idiopathic pulmonary fibrosis Mubarak K.K., Montes-Worboys A., Regev D., Nasreen N., Mohammed K.A., Faruqi I., Hensel E., Baz M.A., Akindipe O.A., Fernandez-Bussy S., Nathan S.D., Antony V.B. Eur Respir J 2012; 39: 133-140
Renin is an angiotensin-independent profibrotic mediator: role in pulmonary fibrosis Montes E., Ruiz V., Checa M., Maldonado V., Melendez-Zajgla J., Montaño M., Ordoñez-Razo R., Cisneros J., García-de-Alba C., Pardo A., Selman M. Eur Respir J 2012; 39: 141-148
Alcohol drinking and risk of subsequent hospitalisation with pneumonia Kornum J.B., Due K.M., Nørgaard M., Tjønneland A., Overvad K., Sørensen H.T., Thomsen R.W. Eur Respir J 2012; 39: 149-155
Initial management of pneumonia and sepsis: factors associated with improved outcome Menéndez R., Torres A., Reyes S., Zalacain R., Capelastegui A., Aspa J., Borderías L., Martín-Villasclaras J.J., Bello S., Alfageme I., de Castro F.R., Rello J., Molinos L., Ruiz-Manzano J. Eur Respir J 2012; 39: 156-162
Interferon release does not add discriminatory value to smear-negative HIV–tuberculosis algorithms Rangaka M.X., Gideon H.P., Wilkinson K.A., Pai M., Mwansa-Kambafwile J., Maartens G., Glynn J.R., Boulle A., Fielding K., Goliath R., Titus R., Mathee S., Wilkinson R.J. Eur Respir J 2012; 39: 163-171
Cost-effectiveness of three strategies for second-line erlotinib initiation in nonsmall-cell lung cancer: the ERMETIC study part 3 Borget I., Cadranel J., Pignon J-P., Quoix E., Coudert B., Westeel V., Dansin E., Madelaine J., Madroszyk A., Friard S., Daniel C., Morin F., Chouaid C., the ERMETIC Collaborative Group Eur Respir J 2012; 39: 172-179
Pulmonary manifestations of immunoglobulin G4-related sclerosing disease Ryu J.H., Sekiguchi H., Yi E.S. Eur Respir J 2012; 39: 180-186
Is community-acquired pneumonia an independent risk factor for cardiovascular disease? Singanayagam A., Singanayagam A., Elder D.H.J., Chalmers J.D. Eur Respir J 2012; 39: 187-196
Matrix metalloproteinases in COPD Churg A., Zhou S., Wright J.L. Eur Respir J 2012; 39: 197-209
Circulating fibrocytes and pulmonary arterial hypertension Gambaryan N., Cohen-Kaminsky S., Montani D., Girerd B., Huertas A., Seferian A., Humbert M., Perros F. Eur Respir J 2012; 39: 210-212
Artificial lung as an alternative to mechanical ventilation in COPD exacerbation Crotti S., Lissoni A., Tubiolo D., Azzari S., Tarsia P., Caspani L., Gattinoni L. Eur Respir J 2012; 39: 212-215
Intermittent hypoxia enhances cancer progression in a mouse model of sleep apnoea Almendros I., Montserrat J.M., Ramírez J., Torres M., Duran-Cantolla J., Navajas D., Farré R. Eur Respir J 2012; 39: 215-217
Malignant mesothelioma in Metsovo, Greece, from domestic use of asbestos: 30 years later Gogali A., Manda-Stachouli C., Ntzani E.E., Matthaiou M., Konstantinidis A.K., Zampira I., Koubaniou C., Dalavanga Y., Stefanou D., Constantopoulos S.H., Daskalopoulos G. Eur Respir J 2012; 39: 217-219
An audit of hypoxaemia, hyperoxaemia, hypercapnia and acidosis in blood gas specimens O'Driscoll B.R., Rudenski A., Turkington P.M., Howard L.S. Eur Respir J 2012; 39: 219-221
Cat litter is a possible trigger for sarcoidosis Drent M., Wijnen P.A., Boots A.W., Bast A. Eur Respir J 2012; 39: 221-222
Prognostic indices for COPD patient management: how many do we need? van Dijk W.D., Schermer T.R.J., van Weel C. Eur Respir J 2012; 39: 223-224
Avoiding backward steps in COPD: looking again at roflumilast Blasco L.M. Eur Respir J 2012; 39: 224-225
Why excessive sleepiness may persist in OSA patients receiving adequate CPAP treatment Castiglioni P., Lombardi C., Cortelli P., Parati G. Eur Respir J 2012; 39: 226-227
Why excessive sleepiness may persist in OSA patients receiving adequate CPAP treatment Vernet C., Redolfi S., Attali V., Konofal E., Brion A., Frija-Orvoen E., Pottier M., Similowski T., Arnulf I. Eur Respir J 2012; 39: 227-228
Viral wheezing is virus specific and not just host specific Korppi M. Eur Respir J 2012; 39: 228-229
Viral wheezing is virus specific and not just host specific Strippoli M-P.F., Spycher B.D., Pescatore A.M., Beardsmore C.S., Silverman M., Kuehni C.E. Eur Respir J 2012; 39: 229
Author Correction “T-helper cell type-1 transcription factor T-bet is upregulated in pulmonary sarcoidosis.” E. Kriegova, R. Fillerova, T. Tomankova, B. Hutyrova, F. Mrazek, T. Tichy, V. Kolek, R.M. du Bois and M. Petrek. Eur Respir J 2012; 38: 1136–1144. Eur Respir J 2012; 39: 230
Author Correction “Properties of the COPD assessment test in a cross-sectional European study.” P.W. Jones, G. Brusselle, R.W. Dal Negro, M. Ferrer, P. Kardos, M.L. Levy, T. Perez, J.J. Soler Cataluña, T. van der Molen, L. Adamek and N. Banik. Eur Respir J 2012; 38: 29–35. Eur Respir J 2012; 39: 230